Attendee Registration - 7:00 am to 1:00 pm

Sunday, September 15, 2019

     
 

Plenary Session

Faculty

Scheduled Time

     
Waldenstrom Award Lecture Award Recipient 9:00 AM
     
Plenary Session: Late Breaking Abstracts F Gay/N van de Donk  
Selected from Submitted Abstracts    
Selected from Submitted Abstracts    
Selected from Submitted Abstracts    
Selected from Submitted Abstracts    
     
Great Debates in Myeloma    
Moderators V Rajkumar/MV Mateos 9:20 AM
     
Should RVD/KRD be considered the standard frontline induction regimen? P Richardson/K Stewart 9:20 AM
Should MRD negativity be the end point of therapy? S Jagannath/J San Miguel 9:40 AM
Is definitive duration or indefinite lenalidomide the right choice for maintenance? P McCarthy/P Moreau 10:00 AM
Should monoclonal antibodies be included for induction in every MM patient? P Voorhees/S Kastritis 10:20 AM
Will ASCT remain a standard of care in 5 years? O Landgren/P Sonneveld 10:40 AM
     
Clinical Trials in Progress   11:00 AM
Moderators D Reece/N van de Donk  
North America S Kumar/R Orlowski 11:00 AM
Europe S Zweegman/T Facon 11:20 AM
S. America V Hungria 11:40 AM
Asia L Qui/K Shimizu 12:00 PM
Australia A Spencer/ J Ho 12:20 AM
     
Welcome to IMW18 Organizers of IMW18  12:40 PM
     
Closing Comments Organizers of IMW17 12:50 AM
     
Program Adjournment   1:00 PM
     
 
 

Workshop Organizers

Christopher Patterson
IMW 17 Secretariat

Dana Farber Cancer Institute
Mayor 548
450 Brookline Avenue
Boston, MA 02215
+1 617 632 6285

cpatterson1@partners.org

 

Follow the IMS

icon facebook icon twitter

Become a Member Today

Housing & Registration

Accommodations


c/o SPARGO, Inc.
11208 Waples Mill Road
Suite 112
Fairfax, VA 22030 USA
888-788-1522 (US Toll free)
+ 1 703-449-6418 (International)

Reserve Now

Contact the IMS

International Myeloma Society

Lisa Sikkink, IMS Assistant

International Myeloma Society
Mayo Clinic
Siebens 6-60
200 First Street SW
Rochester, MN 55905
+1 507 284 3725

adminassistant@myelomasociety.org